Taku Fujimura, Sadanori Furudate, Takeo Maekawa, Hiroshi Kato, Takamichi Ito, Shigeto Matsushita, Koji Yoshino, Akira Hashimoto, Yusuke Muto, Kentaro Ohuchi, et al. Cutaneous angiosarcoma treated with taxane-based chemoradiotherapy: A multicenter study of 90 Japanese cases. Skin Health and Disease. 2022
Takami Okuma, Sadanori Furudate, Yumi Kambayashi, Akira Hashimoto, Setsuya Aiba, Taku Fujimura. Successful treatment of BRAF/MEK inhibitor-resistant advanced cutaneous melanoma with nivolumab plus ipilimumab combination therapy followed by intensity-modulated radiotherapy. The Journal of dermatology. 2021. 48. 9. 1419-1422
T. Fujimura, K. Tanita, Y. Sato, C. Lyu, Y. Kambayashi, Y. Fujisawa, H. Uchi, Y. Yamamoto, A. Otsuka, K. Yoshino, et al. Immune checkpoint inhibitor-induced vitiligo in advanced melanoma could be related to increased levels of CCL19. British Journal of Dermatology. 2020. 182. 5. 1297-1300